<乌鸦传媒>Here's What Happened to Asthma, COPD Admissions After a Big Polluter Shut Down Correlation bolsters evidence that environmental air quality can be modified to good effect May 18, 2022
<乌鸦传媒>Two Drugs Better Than One for 'Rescue' Asthma Therapy Fixed-dose combo inhaler beats good old albuterol May 15, 2022
<乌鸦传媒>Pumping (IV) Iron Linked to Varying Anaphylaxis Risk for Older Adults Study finds risk was low, but unequal across different products Mar 28, 2022
<乌鸦传媒>Nasal Spray Flu Vaccine No Problem for Kids With Asthma Contrary to CDC guidance, nasal spray did not increase asthma exacerbations Mar 28, 2022
<乌鸦传媒>Military Exposure to Burn Pits Under Scrutiny Wearable technology, better registries, "compassionate common sense" urged over denials of harm Mar 17, 2022
<乌鸦传媒>Antisense Drug Slashed Hereditary Angioedema Attacks in Small Study Donidalorsen also allowed longer intervals between treatments Mar 16, 2022
<乌鸦传媒>First Generic OK'd for Popular Asthma, COPD Inhaler FDA approves Mylan's Symbicort copy, reflecting agency's commitment to "increase competition" Mar 15, 2022
<乌鸦传媒>First Drug-Eluting Contact Lens Wins FDA Nod Contact lens releases antihistamine to treat itchy eyes Mar 03, 2022
<乌鸦传媒>Mepolizumab Reduces Need for Oral Steroids in Severe Asthma Some adults on the IL-5 antibody were able to stop taking systemic steroids Mar 02, 2022
<乌鸦传媒>Docs Debate Home Spirometry Is it ready for prime time or is it just a toy with possible serious consequences? Mar 02, 2022
<乌鸦传媒>Does One Mab Come Out on Top for Boosting Lung Function in Asthma? Dupilumab edges out other biologics, but differences were small in indirection comparison Mar 01, 2022
<乌鸦传媒>Mepolizumab Cuts Asthma Flare-Ups in Disadvantaged Kids Black and Hispanic children living in urban settings benefited from biologic therapy Mar 01, 2022
<乌鸦传媒>Many Severe Asthma Patients Achieve Remission on Biologics Year-long freedom from exacerbations without steroids reported in real-world study Feb 28, 2022
<乌鸦传媒>Tezepelumab Benefits Asthma Patients Year-Round Biologic consistently reduced the annualized asthma exacerbation rate Feb 28, 2022
<乌鸦传媒>Medical Approach May Work in Nasal Polyps With Asthma Omalizumab improves polyp symptom scores with low recurrence rate Feb 28, 2022
<乌鸦传媒>Glimpses of Hope for Lebrikizumab in Asthma Subgroup targeting may hold promise for biologic Feb 28, 2022
<乌鸦传媒>One Nutty Gene: Peanut Oral Immunotherapy Outcomes Affected by HLA Allele Carriers of immune system gene variant show better response to treatment Feb 28, 2022
<乌鸦传媒>Dupilumab Continues to Show Promise in Eosinophilic Esophagitis Almost 60% of patients in LIBERTY EoE TREET study achieved remission Feb 27, 2022
<乌鸦传媒>Black, Latinx Adults With Asthma Benefit From Inhaled Glucocorticoid Add-On "Shovel-ready" intervention can help reduce disparities in asthma burden, researchers say Feb 26, 2022
<乌鸦传媒>10 乌鸦传媒 With the Lowest Hourly Rate Calculated by annual salary divided by number of hours worked Feb 23, 2022
<乌鸦传媒>Can Switching Inhalers Reduce Your Carbon Footprint? DPIs and pMDIs both effective for asthma control, but only one may help the earth Feb 08, 2022
<乌鸦传媒>Oral Peanut Allergy Tx May Be Even More Effective in Younger Children Earlier oral immunotherapy "ready for immediate real-world implementation," editorialists argue Jan 20, 2022
<乌鸦传媒>FDA OKs First-in-Class Biologic for Severe Asthma Tezspire is first biologic for this condition with no phenotype or biomarker limitations Dec 20, 2021
<乌鸦传媒>Efforts Needed to De-Escalate Use of Inhaled Corticosteroids in COPD Clinicians are not always following the guidelines Dec 06, 2021
<乌鸦传媒>Are Second COVID Vax Doses Too Risky After Allergic Reaction to the First? Mostly no, says military doctor Nov 10, 2021
<乌鸦传媒>HAE Still Drawing Attention From Drugmakers Two new products show midstage promise in hereditary angioedema Nov 10, 2021
<乌鸦传媒>For Some Food-Allergic Kids (and Parents), Anaphylaxis Isn't the Worst Problem It's the unnecessary, crippling worry about the possibility of it Nov 08, 2021
<乌鸦传媒>Peanut Allergy Patch Still Looks Good 3 Years Later Reactions diminish over time in open-label study Nov 07, 2021
<乌鸦传媒>Guidance on Exposing Babies Early to Peanuts Not Catching On Parents say their docs didn't make a point of recommending it Nov 07, 2021
<乌鸦传媒>Could This Biologic Drug Work in Patients Lacking Its Target? Bizarre finding with omalizumab Nov 07, 2021
<乌鸦传媒>Mixed Results With Anti-Interleukin Biologics in Asthma One shows promise; another fails miserably (and mysteriously) Oct 27, 2021
<乌鸦传媒>Ho-Hum Oral Presentations on COPD Turn Into Fascinating Roundtable Here's why online meetings can be great Oct 22, 2021
<乌鸦传媒>Azithromycin Use Tied to Fewer Exacerbations in Asthma Patients Prophylactic benefits observed in real-world study Oct 20, 2021
<乌鸦传媒>Dupilumab Improves Lung Function for Kids With Asthma Adding monoclonal antibody led to rapid and sustained improvements, study showed Oct 18, 2021
<乌鸦传媒>CHEST 2021: Pandemic Still Dominates 18 Months In But the rest of respiratory and thoracic medicine gets its due, too Oct 15, 2021
<乌鸦传媒>How Many Deaths Will New Cigarette Warnings Prevent? Modeling study comes up with big numbers Sep 24, 2021
<乌鸦传媒>Another Ivermectin Flop; 'Instant' Lung Cancer Decision Tool; Triple COPD Tx & Death Highlights from the European Respiratory Society virtual meeting Sep 08, 2021
<乌鸦传媒>No Burgers for Baby to Minimize Asthma Risk Unexpected consequence seen from "excessive" meat-based foods in infancy Sep 08, 2021
<乌鸦传媒>Good News (Mostly) for Asthma Patients During Pandemic But could one common drug be problematic? Sep 07, 2021
